0.25
0.5
0.75
1.25
1.5
1.75
2
Exploring high‐content screening as a functional genomics tool in biomedicine
Published on Jun 28, 201997 Views
High-content phenotypic screening, encompassing both drug and genomic screenings, constitute an invaluable research and discovery tool, which has been extensively explored by the industry and academia
Related categories
Chapter list
Exploring high content screening as a functional genomics tool in biomedicine00:00
Drug discovery and development01:04
Functional genomics - 101:47
Genome Sequencing - 101:59
The Human Genome at 18 | Feb.2001 Feb.201902:06
The Human Genome in print02:16
The Human Genome in numbers02:21
Genome Sequencing - 202:46
Functional genomics - 202:56
Expression analysis vs functional screening 03:12
Expression analysis vs. functional phenotypic screening04:49
Phenotypic Screening in Functional Genomics - 106:11
Phenotypic Screening in Functional Genomics - 207:39
RNA interference09:05
Homogeneous assays vs. Microscopy based readouts09:34
High Content Screening: getting the whole picture10:58
Automated image analysis - 111:31
Automated image analysis - 212:17
Automated image analysis - 312:20
Automated image analysis - 412:23
Automated image analysis - 512:23
Functional Genomics and RNA based Therapeutics laboratory13:51
Miniaturization : costs and benefits15:00
Video15:32
Functional genomics screening as a tool for the development of novel therapeutics16:03
Functional screening : examples of applications17:31
High Content Screening – How high is high?18:13
Homogeneous assays vs. Microscopy based readouts18:44
High content screening… really?19:27
Image-based cell profiling21:09
High-throughput multiplexed protein readouts25:20
Cell Painting25:23
Identification of host cell factors required for AAV transduction27:19
Adeno-Associated Virus (AAV) vectors27:33
Genome wide siRNA screening for AAV transduction - 128:18
Genome wide siRNA screening for AAV transduction - 228:38
Secondary screening Refinement for AAV specific targets29:55
Genome wide siRNA screening for AAV transduction - 331:27
Secondary screening ɣH2AX foci31:37
DNA Damage Response Top 10 gene targets32:10
Effect of siRNAs on AAV transduction in vivo (liver) Mano32:18
Identification of microRNAs controlling infection by bacterial pathogens34:33
Shigella flexneri and Salmonella Typhimurium35:00
MicroRNAs36:01
Host miRNAs are major regulators of Salmonella and Shigella infection36:29
High-Content Screening: analysis of bacterial infection37:16
Salmonella and Shigella infection are regulated by a different set of miRNAs - 137:28
miRNAs interfere with different stages of Salmonella and Shigella infection38:12
Salmonella and Shigella infection are regulated by a different set of miRNAs - 238:36
Salmonella and Shigella infection are regulated by a different set of miRNAs - 339:08
miR 29b 2 5p increases both early and late steps of Shigella infection - 139:21
miR 29b 2 5p increases both early and late steps of Shigella replication39:44
miR 29b 2 5p increases both early and late steps of Shigella infection - 240:26
miR 29b 2 5p increases filopodia formation and Shigella capture by targeting UNC5C41:17
Suggested reading: Shedding light on microRNA function via microscopy-based screening - 142:03
Suggested reading: Shedding light on microRNA function via microscopy-based screening - 242:32
Suggested reading: Shedding light on microRNA function via microscopy-based screening - 342:43
Suggested reading: Shedding light on microRNA function via microscopy-based screening - 443:05
CRISPR/Cas technology: Precise genome editing and beyond43:47
The CRISPR/ Cas System - 144:00
The CRISPR/ Cas System - 244:27
Nuclease-induced genome editing44:54
CRISPR/Cas system: beyond cutting45:26
CRISPR/Cas system for gene regulation45:51
CRISPR/Cas for disease modelling and large-scale screening47:24
Screening approaches48:14
Thank you48:46